Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.

Rieke, J W; Hafermann, M D; Johnson, J T; LeVeque, F G; Iwamoto, R; Steiger, B W; Muscoplat, C; Gallagher, S C

Rieke, J W; Hafermann, M D; Johnson, J T; LeVeque, F G; Iwamoto, R; Steiger, B W; Muscoplat, C; Gallagher, S C.

Affiliation

Rieke JW; Division of Radiation Oncology, Virginia Mason Medical Center, Seattle, WA 98111.

Int J Radiat Oncol Biol Phys ; 31(3): 661-9, 1995 Feb 01.

Article in En | MEDLINE | ID: mdl-7852133

Subject(s)

Head and Neck Neoplasms/radiotherapy; Pilocarpine/therapeutic use; Xerostomia/drug therapy; Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilocarpine/administration & dosage; Pilocarpine/adverse effects; Radiotherapy/adverse effects; Xerostomia/etiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pilocarpine / Xerostomia / Head and Neck Neoplasms Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 1995 Type: Article

Search on Google

XML

PubMed Links